Search This Blog

Thursday, May 9, 2019

Flexion upgraded to Buy from Hold at Benchmark

Benchmark analyst Bruce Jackson upgraded Flexion Therapeutics to Buy from Hold with a $19 price target
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)